New evidence of the effectiveness of the technology being developed by the French medtech to offset the loss of central vision caused by AMD were presented at a major conference ARVO 2016 in the United States.
New evidence of the effectiveness of the technology being developed by the French medtech to offset the loss of central vision caused by AMD were presented at a major conference ARVO 2016 in the United States.